2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544358, 544368, 544369, 544370, 544373, 544376, 544392, 544399, A61K 31495, C07D24104

Patent

active

044696949

ABSTRACT:
2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, therapeutically acceptable acid addition salts thereof, processes for their preparation, methods of using the derivatives and pharmaceutical compositions of the derivatives are disclosed. The derivatives exhibit dopamine-receptor stimulating activity in a mammal and are useful for treating hyperprolactinemia, galactorrhea, amenorrhea, impotence, Parkinsonism, diabetes, acromegaly, hypertension and other central nervous system disorders.

REFERENCES:
Sianesi, et al., "J. Med. Chem.", vol. 10, 1967, pp. 1144-1148.
Biggi, et al., "J. Amer. Chem. Soc.", vol. 94, 1972, pp. 4700-4707, vol. 95, 1973, pp. 7101-7107.
Toda, et al., "Chemical Abstracts", vol. 76, 1972, col. 72185f.
Veracini, et al., "J. Chem. Soc. Commun.", 1977, pp. 623-624.
Abadir, et al., "J. Chem. Soc.", 1952, pp. 2350-2353.
Nozoe, et al., "Chemical Abstracts", vol. 70, 1969, col. 87244z.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1891899

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.